| pubmed-article:20114 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20114 | lifeskim:mentions | umls-concept:C0031330 | lld:lifeskim |
| pubmed-article:20114 | lifeskim:mentions | umls-concept:C0001645 | lld:lifeskim |
| pubmed-article:20114 | lifeskim:mentions | umls-concept:C0205549 | lld:lifeskim |
| pubmed-article:20114 | lifeskim:mentions | umls-concept:C0054212 | lld:lifeskim |
| pubmed-article:20114 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:20114 | pubmed:dateCreated | 1977-10-31 | lld:pubmed |
| pubmed-article:20114 | pubmed:abstractText | 1-(7-Ethylbenzofuran-2-yl)-2-tert.-butylamino-1-hydroxyethane hydrochloride (bufuralol) is a non-selective beta-adrenoceptor blocking agent which closely resembles propranolol in its properties, including potency. Bufuralol is devoid of alpha-adrenoceptor blocking activity but possesses beta-adrenoceptor agonist activity. beta-Adrenoceptor blocking activity resides mainly in the (-)-isomer though membrane stabilising properties are associated with both optical isomers. | lld:pubmed |
| pubmed-article:20114 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20114 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20114 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20114 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20114 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20114 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20114 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20114 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20114 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20114 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20114 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20114 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:20114 | pubmed:issn | 0004-4172 | lld:pubmed |
| pubmed-article:20114 | pubmed:author | pubmed-author:ParkesM WMW | lld:pubmed |
| pubmed-article:20114 | pubmed:author | pubmed-author:HamiltonT CTC | lld:pubmed |
| pubmed-article:20114 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:20114 | pubmed:volume | 27 | lld:pubmed |
| pubmed-article:20114 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20114 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20114 | pubmed:pagination | 1410-7 | lld:pubmed |
| pubmed-article:20114 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:20114 | pubmed:meshHeading | pubmed-meshheading:20114-An... | lld:pubmed |
| pubmed-article:20114 | pubmed:meshHeading | pubmed-meshheading:20114-Mi... | lld:pubmed |
| pubmed-article:20114 | pubmed:meshHeading | pubmed-meshheading:20114-Sy... | lld:pubmed |
| pubmed-article:20114 | pubmed:meshHeading | pubmed-meshheading:20114-Br... | lld:pubmed |
| pubmed-article:20114 | pubmed:meshHeading | pubmed-meshheading:20114-Va... | lld:pubmed |
| pubmed-article:20114 | pubmed:meshHeading | pubmed-meshheading:20114-He... | lld:pubmed |
| pubmed-article:20114 | pubmed:meshHeading | pubmed-meshheading:20114-Gu... | lld:pubmed |
| pubmed-article:20114 | pubmed:meshHeading | pubmed-meshheading:20114-Gl... | lld:pubmed |
| pubmed-article:20114 | pubmed:meshHeading | pubmed-meshheading:20114-Ra... | lld:pubmed |
| pubmed-article:20114 | pubmed:meshHeading | pubmed-meshheading:20114-Bl... | lld:pubmed |
| pubmed-article:20114 | pubmed:meshHeading | pubmed-meshheading:20114-Li... | lld:pubmed |
| pubmed-article:20114 | pubmed:meshHeading | pubmed-meshheading:20114-Do... | lld:pubmed |
| pubmed-article:20114 | pubmed:meshHeading | pubmed-meshheading:20114-Ca... | lld:pubmed |
| pubmed-article:20114 | pubmed:meshHeading | pubmed-meshheading:20114-Et... | lld:pubmed |
| pubmed-article:20114 | pubmed:meshHeading | pubmed-meshheading:20114-Ra... | lld:pubmed |
| pubmed-article:20114 | pubmed:meshHeading | pubmed-meshheading:20114-Ma... | lld:pubmed |
| pubmed-article:20114 | pubmed:meshHeading | pubmed-meshheading:20114-Ad... | lld:pubmed |
| pubmed-article:20114 | pubmed:meshHeading | pubmed-meshheading:20114-Sp... | lld:pubmed |
| pubmed-article:20114 | pubmed:meshHeading | pubmed-meshheading:20114-An... | lld:pubmed |
| pubmed-article:20114 | pubmed:meshHeading | pubmed-meshheading:20114-Ou... | lld:pubmed |
| pubmed-article:20114 | pubmed:meshHeading | pubmed-meshheading:20114-Be... | lld:pubmed |
| pubmed-article:20114 | pubmed:meshHeading | pubmed-meshheading:20114-Ga... | lld:pubmed |
| pubmed-article:20114 | pubmed:meshHeading | pubmed-meshheading:20114-Re... | lld:pubmed |
| pubmed-article:20114 | pubmed:meshHeading | pubmed-meshheading:20114-Ad... | lld:pubmed |
| pubmed-article:20114 | pubmed:meshHeading | pubmed-meshheading:20114-Ai... | lld:pubmed |
| pubmed-article:20114 | pubmed:meshHeading | pubmed-meshheading:20114-Dr... | lld:pubmed |
| pubmed-article:20114 | pubmed:meshHeading | pubmed-meshheading:20114-Re... | lld:pubmed |
| pubmed-article:20114 | pubmed:year | 1977 | lld:pubmed |
| pubmed-article:20114 | pubmed:articleTitle | Bufuralol, a new beta-adrenoceptor blocking agent in a series of benzofuran-2-ethanolamines. Part 2: pharmacology. | lld:pubmed |
| pubmed-article:20114 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20114 | pubmed:publicationType | In Vitro | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20114 | lld:pubmed |
